MED LIFE S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4 RON | -1.48% |
|
-3.96% | +0.50% |
| Apr. 03 | Med Life S.A. (BVB:M) acquired an unknown majority stake in Personal Genetics Srl. | CI |
| Feb. 29 | Med Life S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2023 | 2.21B 474M | Sales 2024 * | 2.49B 534M | Capitalization | 2.1B 451M |
|---|---|---|---|---|---|
| Net income 2023 * | - | Net income 2024 * | 22 4.72 | EV / Sales 2023 | 0.95 x |
| Net Debt 2023 * | 995M 213M | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.84 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
100
x | Employees | 6,281 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 42.39% |
More Fundamentals
* Assessed data
More news
Latest transcript on Med Life S.A.
More press releases
| 1 day | -1.48% | ||
| 1 week | -2.56% | ||
| Current month | +3.36% | ||
| 1 month | +2.56% | ||
| 6 months | -11.70% | ||
| Current year | +0.50% |
1 week
4.00
4.16
1 month
3.834.30
Current year
3.834.30
1 year
3.834.88
3 years
2.616.50
5 years
1.106.50
10 years
0.966.50
| Managers | Title | Age | Since |
|---|---|---|---|
Mihail Marcu
CEO | Chief Executive Officer | 53 | 06-07-31 |
Adrian Lungu
DFI | Director of Finance/CFO | - | - |
Dorin Preda
DFI | Director of Finance/CFO | 48 | 07-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ovidiu Fer
BRD | Director/Board Member | 40 | 20-11-30 |
| Director/Board Member | 68 | 17-08-31 | |
Dorin Preda
DFI | Director of Finance/CFO | 48 | 07-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.21% | 1 M€ | +9.65% | ||
| 0.00% | 117 M€ | -1.55% | - | |
| 0.00% | 7 M€ | -0.18% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 4 | -1.48% | 31,680 |
| 24-04-18 | 4.06 | -0.49% | 26,114 |
| 24-04-17 | 4.08 | +0.99% | 42,312 |
| 24-04-16 | 4.04 | -1.34% | 57,168 |
| 24-04-15 | 4.095 | -1.68% | 60,155 |
End-of-day quote Bucharest S.E., April 18, 2024
More quotes
MedLife S.A. specializes in medical diagnosis and treatment services for enterprises and individuals. The group is active in the fields of orthopedics and traumatology, general and plastic surgery, spinal surgery, gynecology, paediatrics and maternity services.
At the end of 2021, MedLife S.A. operated 80 clinics, 11 multi- and mono-disciplinary hospitals, 34 medical laboratories (near 200 sampling centres), 17 dental clinics and 22 pharmacies located in Romania.
Calendar
2024-04-28
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
4
RON
Average target price
4.983
RON
Spread / Average Target
+24.58%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +0.50% | 458M | |
| -11.66% | 87.46B | |
| +12.72% | 78.56B | |
| +10.85% | 29.37B | |
| -11.36% | 16.78B | |
| -4.17% | 16.01B | |
| -6.85% | 13.98B | |
| +0.92% | 12.31B | |
| -30.35% | 12.07B | |
| +22.01% | 11.06B |
- Stock Market
- Equities
- M Stock
